Mabpharm Limited (HKG:2181)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.5500
-0.0100 (-1.79%)
At close: Mar 27, 2026

Mabpharm Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-127.95-209.36-210.82-291.74
Depreciation & Amortization
61.3360.751.5543.88
Loss (Gain) From Sale of Assets
---0.030.07
Loss (Gain) From Sale of Investments
-0.12-0.34-0.04-
Stock-Based Compensation
11.8213.479.7812.24
Provision & Write-off of Bad Debts
1.880.430.12-
Other Operating Activities
14.0810.7910.577.05
Change in Accounts Receivable
-76.98-10.32-8.86-0.79
Change in Inventory
-8.97-1.24-47.59-19.79
Change in Accounts Payable
42.89-4.439.7627.19
Change in Unearned Revenue
59.43199.2884.6-30.28
Change in Other Net Operating Assets
18.49-1.5944.0952.72
Operating Cash Flow
-4.157.39-56.89-199.47
Capital Expenditures
-26.14-19.04-125.13-148.67
Sale of Property, Plant & Equipment
--0.040.04
Divestitures
0.1215.39--
Sale (Purchase) of Intangibles
-33.35---
Investment in Securities
---15-
Other Investing Activities
-38.830.1535.13-30.79
Investing Cash Flow
-98.2-3.51-104.96-179.42
Long-Term Debt Issued
81.11123.07122.33-
Total Debt Issued
81.11123.07122.33-
Short-Term Debt Repaid
-49.02-2.25--
Long-Term Debt Repaid
-9.28-31.83-8.17-15.35
Total Debt Repaid
-58.31-34.08-8.17-15.35
Net Debt Issued (Repaid)
22.8189114.17-15.35
Other Financing Activities
-4.53-3.4-1.9-2.43
Financing Cash Flow
18.2885.6112.26-17.78
Foreign Exchange Rate Adjustments
0.010.291.59-6.62
Net Cash Flow
-84139.78-47.99-403.29
Free Cash Flow
-30.2438.35-182.01-348.14
Free Cash Flow Margin
-11.71%44.00%-325.50%-420.04%
Free Cash Flow Per Share
-0.010.01-0.04-0.08
Cash Interest Paid
4.533.41.92.43
Levered Free Cash Flow
-151.36-77.63-245.86-331.03
Unlevered Free Cash Flow
-144.76-71.65-241.37-329.53
Change in Working Capital
34.85181.718229.04
Source: S&P Global Market Intelligence. Standard template. Financial Sources.